Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2013
11/06/2013CN102000125B Ginkgo flavone extraction method
11/06/2013CN101909651B External preparation composition comprising fatty acid-based ionic liquid as active ingredient
11/06/2013CN101890077B Preparation method and quality detection method of rhizoma corydalis pain relieving soft capsules
11/06/2013CN101772490B Trazodone and trazodone hydrochloride in purified form
11/06/2013CN101679523B Novel fully human anti-vap-1 monoclonal antibodies
11/06/2013CN101679425B 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine and its uses in treating cancer and AIDS
11/06/2013CN101679399B Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/06/2013CN101652143B A composition for selective serotonin reuptake inhibition and process thereof
11/06/2013CN101641346B Pyridine and pyrimidine derivatives as mglur2 antagonists
11/06/2013CN101622275B Method of providing disease-specific binding molecules and targets
11/06/2013CN101611005B Substituted acetophenones useful as PDE4 inhibitors
11/06/2013CN101484391B Method for activating and stabilizing dissolved hydrogen in water
11/06/2013CN101448822B Substituted pyrazolopyrimidines
11/06/2013CN101302515B Human antibodies that bind human TNF(alpha)
11/06/2013CN101010302B Sigma receptor inhibitors
11/05/2013US8575215 Treatment of neurodegenerative and cardiovascular disorders
11/05/2013US8575211 Synergistic combination of analgesic compounds
11/05/2013US8575205 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575186 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
11/05/2013US8575172 Pharmaceutical compositions of aripiprazole
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions
11/05/2013US8575145 Triazolopyridine compounds as PIM kinase inhibitors
11/05/2013US8575138 Method for providing neuroprotection
11/05/2013US8575091 Amylin analogues and pharmaceutical compositions thereof
11/05/2013US8575090 Amylin analogues and pharmaceutical compositions thereof
11/05/2013US8574860 Biomarkers for the detection and screening of down syndrome
11/05/2013US8574633 Huperzia serrata (Thunb.) Trev. composition comprising compounded Huperzine A and Huperzine B and methods for preparing it
11/05/2013US8574315 Electrospun structures and methods for forming and using same
11/05/2013CA2731403C Pyrrolidin-3-ylmethyl-amine as orexin antagonists
11/05/2013CA2678165C Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
11/05/2013CA2600169C Pyrazine -2-carboxamide derivatives as mglur5 antagonists
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2507811C Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798]
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
11/05/2013CA2461176C Treatment of central nervous system disorders by use of pdgf or vegf
10/2013
10/31/2013WO2013163576A1 Pantothenate derivatives for the treatment of neurologic disorders
10/31/2013WO2013163455A2 A drug screening platform for rett syndrome
10/31/2013WO2013163402A1 Methods for treatment of 16p11.2 microdeletion syndrome
10/31/2013WO2013163214A1 Formulations and methods for delaying onset of chronic neuropathic pain
10/31/2013WO2013163142A1 Liquid pharmaceutical formulation containing ketorolac and tramadol
10/31/2013WO2013162757A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use
10/31/2013WO2013162413A1 Pharmaceutical composition of an s1p receptor agonist for treating demyelinated disorders (alternatives) and method for producing same
10/31/2013WO2013162363A1 RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
10/31/2013WO2013162061A1 Bicyclic pyrimidine compound
10/31/2013WO2013162050A1 Lactoferrin fusion protein and method for producing same
10/31/2013WO2013162048A1 Injectable preparation
10/31/2013WO2013162046A1 Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
10/31/2013WO2013162027A1 Neuronal differentiation promoter
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161929A1 Pyridinyl morpholinone derivative and drug composition containing same
10/31/2013WO2013161928A1 Oxazolotriazole derivative and drug composition containing same
10/31/2013WO2013161919A1 Trk-INHIBITING COMPOUND
10/31/2013WO2013161913A1 Nitrogenated heterocyclic compound
10/31/2013WO2013161871A1 Thiophene derivative having tlr-inhibiting activity
10/31/2013WO2013161823A1 Orally disintegrating tablet and method for producing same
10/31/2013WO2013161816A1 Amine compound and use thereof for medical purposes
10/31/2013WO2013161471A1 Medicament for treating mental and behavioural disorders
10/31/2013WO2013161312A1 Pyrrolopyridinone derivatives as ttx-s blockers
10/31/2013WO2013161308A1 Amide derivatives as ttx-s blockers
10/31/2013WO2013160896A1 Pomegranate oil for preventing and treating neurodegenerative diseases
10/31/2013WO2013160885A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof
10/31/2013WO2013160728A1 Dual targeting compounds for the treatment of alzheimer's disease
10/31/2013WO2013160273A1 (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes
10/31/2013WO2013159412A1 Method for extracting and separating ginkgolides
10/31/2013WO2013159411A1 Ginkgolide injection and preparation method thereof
10/31/2013WO2013159151A1 Combination meloxicam and xylazine therapy in animals
10/31/2013WO2013134047A3 Aminoquinoline derivatives and uses thereof
10/31/2013WO2013124815A3 Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof
10/31/2013WO2013121334A3 Agents for treating neurodegenerative disorders
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111066A3 Pharmaceutical compositions containing phosphatidylserine and curcumin
10/31/2013WO2013111014A3 Methods and compositions for treating neuron loss in inflammatory bowel disease
10/31/2013WO2013111013A3 Methods for treating alzheimer's disease by administering certain synthetic compounds
10/31/2013WO2013043085A8 (rs)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide compound which exhibits modulatory activity with a commensurate effect, pharmaceutical substance (variants) and use thereof, composition (variants)
10/31/2013WO2003023014A9 Human ion channels
10/31/2013US20130287725 Biocompatible polymers, process for their preparation and compositions containing them
10/31/2013US20130284168 Drug Delivery System And Method For Conscious Sedation/Analgesia
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/30/2013EP2657236A1 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
10/30/2013EP2656855A2 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan-LNAAs (Large Neutral Amino Acids) ratio
10/30/2013EP2656853A1 Method for treating acute cerebral and spinal blood flow disorders of an ischaemic or haemorrhagic nature
10/30/2013EP2655378A1 Compounds and their use as bace inhibitors
10/30/2013EP2655376A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655365A1 2-carboxamide-4-piperazinyl-benzofuran derivative
10/30/2013EP2655356A1 Faah inhibitors
10/30/2013EP2655332A1 Novel morphinans useful as analgesics
10/30/2013EP2655330A1 Substituted pyridines as sodium channel blockers
10/30/2013EP2655329A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
10/30/2013EP2655328A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
10/30/2013EP2655326A1 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
10/30/2013EP2654899A1 Methods for treating neurological conditions and compositions and materials therefor
10/30/2013EP2654751A1 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
10/30/2013EP2654750A1 Novel fused pyridine compounds as casein kinase inhibitors
10/30/2013EP2654743A1 Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease
10/30/2013EP2654742A2 Methods of improving cognitive function
10/30/2013EP2654739A2 Percutaneous absorption preparation containing rivastigmine
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 1833